Skip to main content

and
  1. Article

    Open Access

    NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53/IRF1/type I interferon signaling axis

    Interactions of tumor cells with immune cells in the tumor microenvironment play an important role during malignancy progression. We previously identified that GAS5 inhibited tumor development by suppressing prol...

    Zimu Wang, **g Luo, Hairong Huang, Li Wang, Tangfeng Lv in Cell Death Discovery (2024)

  2. No Access

    Article

    Utilizing metagenomic next-generation sequencing for pathogen detection and diagnosis in lower respiratory tract infections in real-world clinical practice

    Infectious etiologies of lower respiratory tract infections (LRTIs) by the conventional microbiology tests (CMTs) can be challenging. Metagenomic next-generation sequencing (mNGS) has great potential in clinic...

    Tangfeng Lv, Qi Zhao, Jia Liu, Song Wang, Weiwei Wu, Liyun Miao, ** Zhan in Infection (2024)

  3. No Access

    Article

    Response to: Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate

    Yimin Wang, Hedong Han, Fang Zhang, Tangfeng Lv, ** Zhan in British Journal of Cancer (2022)

  4. Article

    Open Access

    Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis

    We indirectly compared the effects of immune checkpoint inhibitors alone (ICI) and ICI-combined chemotherapy (chemo-ICI) in patients with non-small cell lung cancer who had high programmed death-ligand 1 (PD-L...

    Yimin Wang, Hedong Han, Fang Zhang, Tangfeng Lv, ** Zhan in British Journal of Cancer (2022)

  5. Article

    Open Access

    F-circEA1 regulates cell proliferation and apoptosis through ALK downstream signaling pathway in non-small cell lung cancer

    Studies have confirmed that circular RNA (circRNA) has a stable closed structure, which plays an important role in the progression of tumors. Cancers with positive fusion genes can produce associated fusion ci...

    Yin** Huo, Tangfeng Lv, Mingxiang Ye, Suhua Zhu, Jiaxin Liu, Hongbing Liu in Human Cell (2022)

  6. Article

    Open Access

    Metastasis-associated fibroblasts: an emerging target for metastatic cancer

    Metastasis suggests a poor prognosis for cancer patients, and treatment strategies for metastatic cancer are still very limited. Numerous studies have shown that cancer-associated fibroblasts (CAFs), a large c...

    Zimu Wang, Jiaxin Liu, Hairong Huang, Mingxiang Ye, **nying Li in Biomarker Research (2021)

  7. Article

    Open Access

    Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways

    The immune system initiates robust immune responses to defend against invading pathogens or tumor cells and protect the body from damage, thus acting as a fortress of the body. However, excessive responses cau...

    Jiaxin Liu, Yicheng Cheng, Ming Zheng in Signal Transduction and Targeted Therapy (2021)

  8. No Access

    Article

    Bakuchiol Protects Against Acute Lung Injury in Septic Mice

    Sepsis is a systemic inflammatory reaction that may lead to multiple organ damage and acute lung injury (ALI). Bakuchiol (Bak) has been reported to confer protection against inflammation and oxidative stress. ...

    **nxin Zhang, Ning Chang, Yong Zhang, Mingxiang Ye, Zhi** Han, Jie Li in Inflammation (2017)

  9. Article

    Open Access

    The chimeric ubiquitin ligase SH2-U-box inhibits the growth of imatinib-sensitive and resistant CML by targeting the native and T315I-mutant BCR-ABL

    Chronic myeloid leukemia (CML) is characterized by constitutively active fusion protein tyrosine kinase BCR-ABL. Although the tyrosine kinase inhibitor (TKI) against BCR-ABL, imatinib, is the first-line therap...

    Yi Ru, Qinhao Wang, Mei Zhang, Daixing Zhong in Scientific Reports (2016)

  10. No Access

    Article

    Protective autophagy promotes the resistance of HER2-positive breast cancer cells to lapatinib

    Lapatinib, a tyrosine kinase inhibitor of HER2/EGFR, can inhibit the proliferation of HER2-positive breast cancer cells. Additionally, the combination of lapatinib and chemotherapy can markedly prolong patient...

    Suning Chen, **ngmei Zhu, Hongyu Qiao, Mingxiang Ye, **aofeng Lai in Tumor Biology (2016)

  11. Article

    Open Access

    MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition

    Docetaxel is commonly used as an effective chemotherapeutic agent in breast cancer treatment, but the underlying mechanisms of drug resistance are not fully understood. The purpose of this study was to investi...

    Yuan Zhang, Yu Wang, Yifang Wei, Mengyang Li, Shentong Yu in Scientific Reports (2015)